Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - TRASTUZUMAB DERUXTECANO [100 MG PÓ CONC SOL INJ FRS]
Tender Description
TRASTUZUMAB DERUXTECANO [100 MG PÓ CONC SOL INJ FRS]
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.
